HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

N- (4- fluorophenylsulfonyl)- L- valyl- L- leucinal

structure in first source
Also Known As:
SJA 6017; SJA-6017; SJA6017
Networked: 12 relevant articles (4 outcomes, 2 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Shearer, Thomas R: 3 articles (12/2005 - 02/2002)
2. Azuma, Mitsuyoshi: 3 articles (12/2005 - 02/2002)
3. Shearer, T R: 3 articles (04/2001 - 06/2000)
4. Yamaguchi, Masazumi: 2 articles (12/2006 - 12/2005)
5. Tamada, Yoshiyuki: 2 articles (07/2005 - 02/2002)
6. Fukiage, C: 2 articles (04/2001 - 06/2000)
7. Tamada, Y: 2 articles (04/2001 - 06/2000)
8. Azuma, M: 2 articles (04/2001 - 06/2000)
9. Barut, Seref: 1 article (10/2008)
10. Sa─čmanligil, Ayhan: 1 article (10/2008)

Related Diseases

1. Cataract (Cataracts)
2. Spinal Cord Injuries (Spinal Cord Injury)
3. Glaucoma
4. Anoxia (Hypoxia)
5. Ischemia

Related Drugs and Biologics

1. calpain inhibitors
2. Calcium
3. Sodium Selenite (Selenite)
4. AK 295
5. calpain inhibitor III
6. Retinaldehyde (Retinal)
7. Calpain
8. Oxygen
9. N- (4- fluorophenylsulfonyl)- L- valyl- L- leucinal
10. Cysteine Proteinase Inhibitors

Related Therapies and Procedures

1. Lenses
2. Intraperitoneal Injections
3. Oral Administration